137 related articles for article (PubMed ID: 8597811)
1. Proliferation and maturation indices in nephrogenic rests and Wilms tumor; the emergence of heterogeneity from dormant nodular renal blastema.
Bove KE; Lewis C; Debrosse BK
Pediatr Pathol Lab Med; 1995; 15(2):223-44. PubMed ID: 8597811
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.
Beckwith JB; Kiviat NB; Bonadio JF
Pediatr Pathol; 1990; 10(1-2):1-36. PubMed ID: 2156243
[TBL] [Abstract][Full Text] [Related]
4. Assessment of proliferative activity in Wilms' tumour.
Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
[TBL] [Abstract][Full Text] [Related]
5. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors.
Wünsch L; Flemming P; Glüer S
Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029
[TBL] [Abstract][Full Text] [Related]
6. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation.
Mourad WA; Lavallee-Grey M; Pappenhausen P; Essig YP; Rowlands DT
Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
10. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
11. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
Muir TE; Cheville JC; Lager DJ
Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
[TBL] [Abstract][Full Text] [Related]
12. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney development.
Vuononvirta R; Sebire NJ; Messahel B; Perusinghe N; Reis-Filho JS; Pritchard-Jones K; Vujanic GM; Jones C
Clin Cancer Res; 2009 Apr; 15(8):2723-30. PubMed ID: 19318497
[TBL] [Abstract][Full Text] [Related]
14. Ureteric Bud-derivatives in Wilms Tumor and Nephrogenic Rest.
Sarkany B; Kovacs G; Banyai D
In Vivo; 2021; 35(4):2159-2162. PubMed ID: 34182492
[TBL] [Abstract][Full Text] [Related]
15. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma.
Bethwaite PB; Delahunt B; Holloway LJ; Thornton A
Pathology; 1995 Jan; 27(1):1-4. PubMed ID: 7603742
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
17. Renal pathology in WAGR syndrome.
Ariel I; Abeliovich D; Bar-ziv J; Hochberg A
Pediatr Pathol Lab Med; 1996; 16(6):1013-21. PubMed ID: 9025899
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
[TBL] [Abstract][Full Text] [Related]
19. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
Ramani P; Cowell JK
J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of SALL4 in Wilms tumors and developing kidney.
Deisch J; Raisanen J; Rakheja D
Pathol Oncol Res; 2011 Sep; 17(3):639-44. PubMed ID: 21258884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
